Latest News and Press Releases
Want to stay updated on the latest news?
-
SANTA ROSA, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, today reported financial results...
-
Improved Patient Outcomes and Compelling Economic Data with the Ovation® Platform and a Fast-Track EndoVascular Aortic Repair (EVAR) Protocol SANTA ROSA, Calif., Nov. 3, 2015 (GLOBE NEWSWIRE)...
-
Compelling Evidence that the Ovation® System Expands and Improves Endovascular Aortic Repair to More Patients SANTA ROSA, Calif., Nov. 3, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies,...
-
SANTA ROSA, Calif., Oct. 26, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, today reported preliminary...
-
SANTA ROSA, Calif., Sept. 15, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV) announced today that the first European patients have been treated successfully with the Ovation iX...
-
SANTA ROSA, Calif., Aug. 24, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, announced today the first patient...
-
SANTA ROSA, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today reported financial...
-
SANTA ROSA, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, and Capital Royalty Partners II...
-
SANTA ROSA, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV) announced today that the U.S. Food and Drug Administration (FDA) approved the Ovation iX...
-
SANTA ROSA, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation Abdominal Stent Graft platform, announced today two major clinical...